| 1. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 2. | | Recruiting | Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer |
| 3. | | Recruiting | Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Conditions: breast cancer in situ; intraductal breast carcinoma |
| 4. | | Recruiting | Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 5. | | Recruiting | Arsenic Trioxide in Treating Men With Germ Cell Cancer
Conditions: recurrent testicular cancer; extragonadal germ cell tumor |
| 6. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
| 7. | | Recruiting | Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 8. | | Recruiting | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
Condition: ovarian epithelial cancer |
| 9. | | Recruiting | Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 10. | | Not yet recruiting | Celecoxib in Preventing Breast Cancer in Premenopausal Women
Conditions: Breast Cancer; breast cancer in situ; lobular breast carcinoma in situ |
| 11. | | Recruiting | Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
Conditions: stage 0 cervical cancer; high-grade squamous intraepithelial lesion |
| 12. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 13. | | Recruiting | Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 14. | | Recruiting | Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
Conditions: stage III melanoma; Recurrent Melanoma |
| 15. | | Recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus |
| 16. | | Recruiting | Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
Conditions: stage III mantle cell lymphoma; stage IV mantle cell lymphoma; stage II mantle cell lymphoma |
| 17. | | Recruiting | Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia in remission; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ... |
| 18. | | Recruiting | Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: extensive stage small cell lung cancer |
| 19. | | Recruiting | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Older Patients With Previously Untreated Non-Hodgkin's Lymphoma
Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
| 20. | | Recruiting | Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 21. | | Recruiting | Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 22. | | Recruiting | Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder |
| 23. | | Recruiting | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: Nose Cancers; Oral Cancer; Throat Cancer |
| 24. | | Recruiting | Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 25. | | Recruiting | Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 26. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
Conditions: Adult Medulloblastoma; adult anaplastic ependymoma; adult ependymoma; adult supratentorial primitive neuroectodermal tumor (PNET) |
| 27. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 28. | | Recruiting | Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma |
| 29. | | Recruiting | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: adult Hodgkin's lymphoma |
| 30. | | Recruiting | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 31. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 32. | | Recruiting | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 33. | | Recruiting | Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma |
| 34. | | Recruiting | Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 35. | | Not yet recruiting | Dexamethasone With or Without CC-5013 in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 36. | | Recruiting | Docetaxel in Treating Older Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 37. | | Not yet recruiting | Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer
Conditions: stage II penile cancer; stage III penile cancer; stage IV penile cancer |
| 38. | | Recruiting | Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer |
| 39. | | Recruiting | Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
| 40. | | Recruiting | Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Conditions: adult neurofibrosarcoma; stage III adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage II adult soft tissue sarcoma; ... |
| 41. | | Recruiting | Exemestane Compared With Anastrozole, With or Without Celecoxib, in Treating Postmenopausal Women After Surgery for Primary Breast Cancer
Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer |
| 42. | | Recruiting | FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 43. | | Recruiting | FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer |
| 44. | | Recruiting | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 45. | | Recruiting | Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
Condition: Non-small cell lung cancer |
| 46. | | Recruiting | Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
Conditions: Stage IV Renal Cell Cancer; stage III renal cell cancer |
| 47. | | Recruiting | Gemcitabine and Capecitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Conditions: extrahepatic bile duct cancer; Gallbladder Cancer |
| 48. | | Recruiting | Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
| 49. | | Recruiting | Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
Conditions: adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 50. | | Recruiting | Gemcitabine, Carboplatin, and Bortezomib in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
